23:07 , Apr 23, 2018 |  BC Extra  |  Company News

Management tracks: Probiodrug, Alder

Neurology company Probiodrug AG (Euronext:PBD) said Chairman and CEO Konrad Glund will retire, effective April 30. He will be succeeded by Ulrich Dauer, who was CEO of Ventaleon GmbH (Gemünden, Germany). Probiodrug also said CFO...
17:34 , Feb 3, 2017 |  BC Week In Review  |  Financial News

Capnia financial update

On Jan. 27, inflammation, neurology and diagnostic company Capnia Inc. (NASDAQ:CAPN) entered into a 30-month stock purchase agreement with Aspire Capital Fund for up to $17 million. Capnia Inc. (NASDAQ:CAPN), Redwood City, Calif. ...
07:00 , Jul 11, 2016 |  BC Week In Review  |  Financial News

Capnia completes private placement of convertible preferred stock

Capnia Inc. (NASDAQ:CAPN), Redwood City, Calif.   Business: Diagnostic   Date completed: 2016-07-06   Type: Private placement of convertible preferred stock   Raised: $3.2 million   Shares: 3,151   Price: $1,000   Shares after offering:...
08:00 , Feb 29, 2016 |  BC Week In Review  |  Clinical News

Nasal CO2: Phase II started

Capnia began a single-blind, U.S. Phase II trial to evaluate nasal CO2 in about 50 patients. Patients will receive 6 doses of nasal CO2 or placebo, with each dose given over 10 seconds, in the...
08:00 , Jan 18, 2016 |  BC Week In Review  |  Financial News

Capnia completes private placement of convertible preferred stock and warrants

Capnia Inc. (NASDAQ:CAPN), Redwood City, Calif.   Business: Diagnostic   Date completed: 2016-01-11   Type: Private placement of convertible preferred stock and warrants   Raised: $5.4 million   Shares: 5,445   Price: $1,000   Shares...
07:00 , Oct 19, 2015 |  BC Week In Review  |  Financial News

Capnia completes private placement of convertible preferred stock and warrants

Capnia Inc. (NASDAQ:CAPN), Redwood City, Calif.   Business: Diagnostic   Date completed: 2015-10-15   Type: Private placement of convertible preferred stock and warrants   Raised: $4.6 million   Shares: 4,555   Shares outstanding prior: 8...
07:00 , Sep 7, 2015 |  BC Week In Review  |  Clinical News

Nasal CO2: Phase II started

Capnia said investigators began an open-label, U.S. Phase II trial to evaluate 0.5 L/minute nasal CO2 given for 10 seconds in each nostril up to 6 times to treat 1 cluster headache attack in a...
07:00 , Aug 3, 2015 |  BC Week In Review  |  Financial News

Capnia financial update

Capnia Inc. (NASDAQ:CAPN), Redwood City, Calif.   Business: Diagnostic   Date announced: 2015-07-27   Note: Capnia entered into a two-year stock purchase agreement with Aspire Capital for up to $10 million.  ...
02:18 , Apr 15, 2015 |  BC Extra  |  Company News

Management tracks

Infectious disease play Eiger Biopharmaceuticals Inc. (San Carlos, Calif.) named Joanne Quan as CMO. Quan was VP of new product clinical development at InterMune Inc. , which Roche (SIX:ROG; OTCQX:RHHBY) acquired. Drug delivery company scPharmaceuticals...
08:00 , Jan 5, 2015 |  BioCentury  |  Finance

2015 Financial Markets Preview: Show me in 2015

2015 Financial Markets Preview Bankers and buysiders see no reason for the biotech sector to slow down in 2015 as a new innovation cycle continues to churn out products and drive growth in the large-...